News

Bio-Medical Services, Inc. Is Acquired By ALK-Abello A/S

AUSTIN, TEXAS (March 2014) – Statesman Corporate Finance, LLC (“Statesman”) is pleased to announce that the assets of Bio-Medical Services, Inc. (“Bio-Medical Services”), an Austin based veterinary reference laboratory that pioneered in vitro serum IgE allergy testing in the veterinary industry, have been acquired by ALK-Abelló A/S (“ALK”), (NASDAQ OMX Copenhagen: ALK B), the world’s leading allergen extract manufacturer, which is located in Hørsholm, Denmark. The transaction was completed on February 11, 2014.

Since 1923, ALK has exemplified scientific leadership in the field of allergy research, and has remained committed to the treatment of allergic disease in humans. Bio-Medical Services introduced in vitro serum IgE allergy testing to the veterinary industry in 1989, and has a proven track record for treating allergic disease for dogs, cats, and horses. With this acquisition, ALK is now positioned to expand its allergy focus to include the very important veterinary allergy market.

“This partnership will allow us to provide complete allergy management resources to veterinary dermatologists and general practitioners alike. By leveraging the expertise of both companies, we will enhance and expand the ACTT® Allergy Management program to provide the most comprehensive resource for allergy testing and treatment in the industry. Dr. Keesee and I are thrilled to become part of the ALK team,” stated Pamela Blaine, Director of Marketing for Bio-Medical Services.

“We are excited about our partnership with Bio-Medical Services and the opportunity to expand our knowledge and resources in the field of veterinary allergy care. We share the commitment to customer service that Bio-Medical Services customers have known, and to provide allergy testing and treatment solutions that will improve the lives of allergic pets,” stated Jose A. Moreno Toscano, President of ALK-Abello, Inc.

The ACTT Allergy Program with ALK will include serum IgE allergy testing, bulk allergen sales for the veterinary dermatologist, and allergen-specific immunotherapy treatment, including the new ACTT Allergy Drops™, sublingual immunotherapy. Together, ALK and Bio-Medical Services will fight the cause of allergic disease for people and their pets.

“I am excited that the company will go forward in the capable hands of ALK and Bio-Medical Services team members. It has been a long and exciting journey from 1985 to 2014, and I am awed to think about all of the animals that have been treated and helped as a result of serum allergy testing,” stated Rosalie Mandy, CEO of Bio-Medical Services.

Statesman Corporate Finance, LLC served as the exclusive financial advisor to Bio-Medical Services, Inc. The Statesman transaction team was led by Managing Director Lawrence (Larry) Schumann. Brad Knippa and David Garcia with Jackson Walker served as legal counsel for Bio-Medical Services. Jerry Keys, with Matheson Keys & Kordzik, led the legal team that advised ALK.

ALK is a research driven, global pharmaceutical company focusing on allergy treatment, prevention and diagnosis. As the world leader in allergy immunotherapy, a treatment given to increase immunity to substances causing allergic symptoms, ALK is devoted to improving the quality of life for people and pets with allergies by creating products that treat the cause of allergies. ALK and the Asthma and Allergy Foundation of America have partnered to create a unique online resource on allergy immunotherapy for patients: www.fightthecauseofallergy.org. ALK is also committed to supporting the business of allergy by providing diagnostic tools, automation software and customized business, technical and clinical consulting services.

Bio‐Medical Services is a veterinary reference laboratory specializing in allergy testing and treatment for dogs, cats and horses. Founded in 1989, Bio‐Medical Services was the first laboratory to develop a commercial application for in vitro allergy diagnostics in the veterinary industry.

Statesman Corporate Finance, LLC is a leading middle market investment bank headquartered in Houston, Texas and with an office in Austin, Texas. Statesman provides merger and acquisition sell-side and buy-side advisory services and general corporate financial advisory services to small and middle-market companies.

Statesman Contact:
Larry Schumann
Managing Director – Austin Office
(512) 372-1000
lschumann@statesmanbiz.com